Tag: USFDA

Beyond Generics: Lupin Limited’s Dapagliflozin Approval Highlights Strategic Depth in Chronic Care

USFDA Grants Final ANDA Approval to Indoco Remedies for Epilepsy Drug

USFDA Flags Compliance Issues at Sun Pharma & Aurobindo Pharma After Inspections

NATCO Pharma’s API Facility Cleared by U.S. FDA in Mekaguda Inspection